Cellular assays development


Cellular assays development


Fluofarma provides services for target and drug discovery based on cellular assays development.

Cultured human cells enable functional analysis. The Fluofarma drug discovery process is wholly founded on cellular assays to ensure that compounds are tested in a physiological context.

Fluofarma offers predictive tools for cellular assays development including:

  • Panel of human cancer cell lines representative of major tumor types
  • Engineered cell lines overexpressing specific targets for focused screening
  • Cell lines expressing recombinant biosensors for specific molecular analysis
  • Several primary culture systems for organ-specific mechanism of action and/or toxicity studies

Fluofarma has developed a panel of cellular assays that enable the measurement of more than hundred different molecular events in living cells. All of Fluofarma's cellular assays can be performed in multiplexed conditions, meaning that you can simultaneously monitor several parameters at the single-cell level.

Thanks to the creativity and the strong know-how of its scientists, Fluofarma offers custom-made cellular screening development to fulfill your research needs.


For more information on our cellular assays development


If you need to have further details on our Cellular assays development, do not hesitate to contact-us.







Cellular assays development

FOCUS: Anticancer drugs profiling
Fluofarma has developed DCffer® method, a powerful approach to compare and profile your anti-cancer drugs. Read more [+]